Skip to main content
PEGASUS MERCANTILE INC. logo

PEGASUS MERCANTILE INC. — Investor Relations & Filings

Ticker · LOAN ISIN · CA70557Y2042 LEI · 529900BGK3BYC4VSF690 CSE Financial and insurance activities
Open in API
Filings indexed 424 across all filing types
Latest filing 2025-08-27 Regulatory Filings
Country CA Canada
Listing CSE LOAN

About PEGASUS MERCANTILE INC.

https://xtacytherapeutics.com/

Pegasus Mercantile Inc. is a diversified venture capital firm and prospect generator that provides financial, operational, and management assistance to high-growth companies. The firm specializes as an incubator for early-stage investments within the wellness consumer goods market, focusing on biotechnology, hemp, CBD, functional mushrooms, and psychedelics. Its investment strategy targets solutions for chronic pain, depression, and mental illness, often utilizing pioneering techniques such as micro-dosing organic and synthetic compounds. Pegasus Mercantile assists portfolio companies from startup through commercialization, specializing in navigating complex regulatory requirements, including clinical trials, patenting, and legislative approvals. The firm also provides debt financing facilities.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a CEO’s certificate under Canadian NI 52-109 Form 52-109FV2 certifying the interim financial report and interim MD&A for the quarter ended June 30, 2025. It is not the interim report itself nor the MD&A; rather, it is a regulatory certification letter. This does not match any specific category such as interim report (IR), MD&A (MDA), or announcement of publication (RPA). Therefore, it falls under the fallback category for miscellaneous regulatory filings.
2025-08-27 English
Interim MD&A - English.pdf
Management Reports Classification · 91% confidence The document is titled “Management’s Discussion and Analysis For the nine months ended June 30, 2025 and 2024” and contains narrative commentary on financial condition, results of operations, outlook, forward-looking statements, going concern discussion and business description. It is a standalone MD&A for an interim (nine-month) period rather than a press release, earnings highlights, or the full interim financial statements themselves. This corresponds to our Management Reports category (MDA).
2025-08-27 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements' for the nine months ended June 30, 2025. It includes comprehensive financial statements (Statement of Financial Position, Statement of Changes in Shareholders' Deficit, Statement of Loss and Comprehensive Loss, and Statement of Cash Flows) along with detailed notes to the financial statements. It is a formal interim financial report, not an announcement or a summary, and contains substantive financial data. 9M 2025
2025-08-27 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 90% confidence The document is a statutory Canadian securities filing titled “Form 45-106F1 Report of Exempt Distribution,” detailing a private placement under NI 45-106. It is not an earnings release, investor presentation, management discussion, or dividend notice but rather a compliance/regulatory submission. It does not match any more specific category in the taxonomy, so it falls under the fallback “Regulatory Filings” category (RNS).
2025-06-19 English
Interim MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled “Management’s Discussion and Analysis For the six months ended March 31, 2025 and 2024” and consists entirely of narrative commentary on the company’s financial condition, results of operations, business description, corporate updates, outlook, going concern, and acquisition details. It does not include full financial statements, nor is it a brief shareholder announcement. This aligns precisely with a Management Discussion & Analysis (MDA) report. Therefore, it is classified as a Management Report (MDA).
2025-05-28 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 80% confidence The document is a certification (Form 52-109FV2) by the CFO of Pegasus Mercantile Inc. concerning the interim financial report and interim MD&A for the period ended March 31, 2025. It is not the interim report itself (which would be classified as IR), nor is it an auditor’s report (AR). It is a regulatory compliance filing under Canadian NI 52-109, serving as a certificate rather than substantive financial statements or a management discussion. This falls into the fallback category for miscellaneous regulatory filings (RNS).
2025-05-28 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.